Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventriculat systolic dysfunction | Charles Explorer

Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventriculat systolic dysfunction

Publication at Faculty of Physical Education and Sport |

2006

Abstract

Ivabradine, BEAUTIFUL Study

Person